Cellular therapy for lymphoma
An oncology breakthrough at the Barbara Ann Karmanos Cancer Institute is a type of cell therapy called chimeric antigen receptor T cell therapy (CAR-T), a new type of immunotherapy born out of years of cellular therapy research.